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Abstract 
Background: Microbes have been extensively explored for production of environment‑friendly fuels and chemicals. 
The microbial fermentation pathways leading to these commodities usually involve many redox reactions. This makes 
the fermentative production of highly reduced products challenging, because there is a limited NADH output from 
glucose catabolism. Microbial production of n-butanol apparently represents one typical example.
Results: In this study, we addressed the issue by adjustment of the intracellular redox state in Escherichia coli. This 
was initiated with strain BuT‑8 which carries the clostridial CoA‑dependent synthetic pathway. Three metabolite 
nodes in the central metabolism of the strain were targeted for engineering. First, the pyruvate node was manipu‑
lated by enhancement of pyruvate decarboxylation in the oxidative pathway. Subsequently, the pentose phosphate 
(PP) pathway was amplified at the glucose‑6‑phosphate (G6P) node. The pathway for G6P isomerization was further 
blocked to force the glycolytic flux through the PP pathway. It resulted in a growth defect, and the cell growth was 
later recovered by limiting the tricarboxylic acid cycle at the acetyl‑CoA node. Finally, the resulting strain exhibited a 
high NADH level and enabled production of 6.1 g/L n-butanol with a yield of 0.31 g/g‑glucose and a productivity of 
0.21 g/L/h.
Conclusions: The production efficiency of fermentative products in microbes strongly depends on the intracellular 
redox state. This work illustrates the flexibility of pyruvate, G6P, and acetyl‑CoA nodes at the junction of the central 
metabolism for engineering. In principle, high production of reduced products of interest can be achieved by indi‑
vidual or coordinated modulation of these metabolite nodes.
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Background
Our daily life is tightly linked to the petroleum-based 
industries. However, the rising price, the insecure sup-
ply, and the environmental concern of fossil fuels have 
currently overshadowed these industries. Consequently, 
it provokes the demand for renewable and environment-
friendly fuels and chemicals [1]. The bioprocess pro-
duction of these chemical commodities appears to be 
appealing [2, 3]. Bio-based fuels and chemicals of interest 
are generally fermentative products of living microbes. 
The microbial fermentation pathways involve many 
redox reactions, which usually require NADH and NAD+ 
as cofactors. With NAD+ as an electron acceptor, the oxi-
dation of sugars produces NADH. NAD+ is regenerated 
when intermediate metabolites in the sugar catabolism 
are subsequently reduced at the expense of NADH. The 
result of the reductive reactions usually leads to produc-
tion of ethanol, lactate, and succinate as exemplified in 
fermentative Escherichia coli [4]. Therefore, maintaining 
the redox balance of NADH and NAD+ is a key to ensure 
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Fermentative production of n-butanol in Clostridium 
species is a well-known bioprocess [5]. The fermenta-
tion process mainly consists of the acidogenesis and the 
solventogenesis phase [6]. In the acidogenesis stage, the 
growing Clostridium species ferment glucose to mainly 
produce acetate and butyrate. Upon reaching the station-
ary growth phase, the bacteria re-assimilate these organic 
acids, while acetone, n-butanol, and ethanol are pro-
duced as end products. In view of the clostridial synthetic 
pathway, the direct synthesis of n-butanol from glucose 
can cause the NADH/NAD+ redox imbalance because 
more NADH is required in the synthetic pathway than 
that generated in the glycolytic pathway. This may explain 
why the synthesis of n-butanol in Clostridium species 
proceeds in two stages.
n-Butanol is an alternative fuel of potential because 
its property is superior to ethanol in terms of the energy 
density, the vapor pressure, and hygroscopicity [7]. 
Moreover, n-butanol can be used for the transportation 
fuel after blended with gasoline at any concentrations 
and transported with the existing pipeline infrastruc-
ture [8]. These merits make microbial production of 
n-butanol industrially attractive. Many approaches have 
been proposed for production of n-butanol in a variety 
of surrogate strains [9–12]. However, these attempts are 
generally discouraged by their low n-butanol titer. Rec-
ognized as the biotechnology workhorse, E. coli has been 
commonly employed to produce value-added chemicals 
and biofuels [13, 14]. Production of n-butanol in E. coli is 
proven feasible after introduction of the clostridial syn-
thetic pathway into the strain [9, 15, 16]. In addition, the 
production titer is improved by manipulating pyruvate 
dehydrogenase (PDH) and formate dehydrogenase (FDH) 
in glycolysis to increase the NADH availability in the cell 
[15, 17, 18]. Recently, we have proposed a new produc-
tion platform based on two strains: a butyrate-conversion 
strain and a butyrate-producing strain [19]. The dual-cul-
ture system rebuilds a redox-balanced synthetic pathway, 
which enables effective production of n-butanol.
Microbial production of a highly reduced fermentation 
product such as n-butanol remains challenging because 
there is a limited NADH output from glucose catabo-
lism. This issue was addressed by rerouting the central 
metabolic pathways in E. coli. The NADH availability 
is manifested by the interplay of glycolysis, the pentose 
phosphate (PP) pathway, and the tricarboxylic acid 
(TCA) cycle involved in central metabolism (Fig.  1). In 
addition to PDH and FDH, the enzymes that regulate the 
metabolite pools at the junction of central metabolism 
were systematically manipulated to modulate the intra-
cellular NADH. As a result, the engineered strain with 
the remodeled pathways enabled effective production of 
n-butanol.
Results and discussion
Amplification of the pyruvate oxidation pathway
As shown in Fig.  1, the reductive synthesis of one 
n-butanol from one glucose requires more NADH than 
that provided in glycolysis. Therefore, the approach of 
NADH replenishment is expected to favor the fermenta-
tive production of n-butanol. In this context, the pyruvate 
node connecting glycolysis and the TCA cycle appears to 
be a potential target for manipulation. In E. coli, pyruvate 
is oxidized to acetyl-CoA by a reaction mediated by PDH 













































Fig. 1 The central metabolic pathways leading to n-butanol in E. 
coli. The dotted lines denote the heterologous pathways. The CoA‑
dependent synthetic pathway of n-butanol is composed of heterolo‑
gous phaA, hbd, crt, ter, and adhE2 genes as shown. Three metabolite 
nodes including G6P, pyruvate, and acetyl‑CoA are targeted for engi‑
neering and marked. The genes involved in the metabolic pathways: 
aceEF‑lpdA*, pyruvate dehydrogenase complex; adhE, aldehyde‑
alcohol dehydrogenase; adhE2, butyraldehyde‑butanol dehydroge‑
nase; crt, crotonese; gltA, citrate synthase; hbd, 3‑hydroxybutyryl‑CoA 
dehydrogenase; ldhA, lactate dehydrogenase; fdh1, formate 
dehydrogenase; frdA, subunit of fumarate reductase; pflB, pyruvate 
formate‑lyase; pgi, phosphoglucose isomerase; pgl, lactonase; phaA, 
acetoacetyl‑CoA thiolase; pta, phosphate acetyltransferase; ter, 
trans‑enoyl‑CoA reductase; udhA, transhydrogenase; zwf, glucose‑
6‑phosphate dehydrogenase. The deleted genes are indicated by “X”. 
Abbreviations: Ace acetate; EtOH ethanol; F6P fructose‑6‑phosphate; 
Lac lactate; For formate; G6P glucose‑6‑phosphate; Glc glucose; OAA 
oxaloacetate; PEP phosphoenolpyruvate; 3-PGA 3‑phosphoglyceral‑
dehyde; Pyr pyruvate; Suc succinate
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(PFL) under the fermentative growth [4]. Formate is the 
reduced product of the PFL reaction. Found in other 
microbes, FDH such as Candida boidinii fdh and Saccha-
romyces cerevisiae fdh1 catalyzes oxidation of formate to 
CO2 associated with NADH generation [20]. These two 
genes have been employed in E. coli to elevate intracel-
lular NADH, resulting in an increase in n-butanol pro-
duction [17, 21]. Accordingly, S. cerevisiae fdh1 under 
the control of the trc promoter (Ptrc) without lacO was 
integrated into strain BuT-8. Strain BuT-8 was previously 
constructed with a CoA-dependent pathway of n-butanol 
consisting of the constitutive λPL promoter (PλPL)-driven 
hbd, crt, and adhE2 of Clostridium acetobutylicum, phaA 
of Cupriavidus necator, and ter of Treponema denti-
cola [19]. In addition, the undesired pathways involving 
endogenous adhE, ldhA, pta, and frdA were removed 
from this strain to curtail carbon waste and conserve 
NADH. Equipped with S. cerevisiae fdh1, the result-
ing strain BuT-8-Fdh1 produced 3.1  g/L n-butanol at 
24 h (Fig. 2a). This production titer accounts for a 25 % 
increase over that for strain BuT-8 (Table 1).
In contrast to PFL, the PDH reaction generates NADH 
as the reduced product. Therefore, manipulation of the 
PDH level is expected to alter intracellular NADH. This 
was conducted by fusion of PλPL with aceEF operon 
to enhance the gene expression in strain BuT-8-Fdh1. 
To render PDH less sensitive to NADH inhibition, the 
endogenous lpdA (encoding dihydrolipoamide dehydro-
genase) was deleted and a mutation site (E354K) in lpdA 
was additionally created [22]. The mutant lpdA* under 
the control of PλPL was then inserted into strain BuT-8-
Fdh1 to obtain strain BuT-9. Consequently, strain BuT-9 
exhibited 1.3-fold higher PDH activity and 45  % higher 
NADH level as compared to strain BuT-8 (Table  1). 
The accumulated pyruvate in strain BuT-8 was greatly 
reduced and carbon flux was diverted from the synthetic 
pathways of byproducts (Table  2). Strain BuT-9 finally 
produced 4.3 g/L n-butanol (Fig. 2b), which accounts for 
a 60 % increase over that in strain BuT-8 (Table 1).
The similar approach has been previously applied for 
n-butanol production in E. coli that carries the CoA-
dependent synthetic pathway. By using C. boidinii fdh, 
the best strain in their study showed a 1.3-fold increase 
in n-butanol production [17]. In another work, a 1.6-
fold improvement in the production yield was reported 
for a strain with enhanced PDH [15]. In addition, it was 
reported that a strain with the optimal activation of PDH 
exhibited a 12  % improvement in n-butanol production 
[18]. Further improvement of the strain by optimization 
of S. cerevisiae fdh1 expression led to a 35.4 % increase in 
the production titer [18]. These studies were conducted 
using super-rich TB medium, in contrast to ours which 
employed M9Y medium. Although displaying a various 
degree of improvement in the n-butanol production, 
aforementioned studies and ours illustrate the feasibility 
in manipulating the pyruvate node to modulate intracel-
lular NADH.
Amplification of the pentose phosphate pathway
The glycolytic pathway bifurcates at the glucose-6-phos-
phate (G6P) node (Fig. 1). With G6P as a starting metabo-
lite, the PP pathway produces precursors for the synthesis 
of nucleic acids and aromatic amino acids and also pro-
vides a major source of NADPH for biosynthesis which is 
involved in most of the reductive pathways [4]. It is possi-
ble to increase NADH availability by manipulation of the 
G6P node. G6P dehydrogenase (encoded by zwf) cata-
lyzes the first step in the PP pathway. Therefore, zwf of 
strain BuT-9 was fused to PλPL. In E. coli, pyridine nucle-
























































































Fig. 2 Production of n-butanol in strains with the amplification of 
the pyruvate oxidation pathway. The engineered E. coli strains were 
grown in M9Y medium containing 20 g/L glucose. The fermentations 
were conducted under the oxygen-limited condition for 24 h. The 
experiments were conducted in triplicate. Keys: a the fermentation 
performance for strain BuT‑8‑Fdh1; b the fermentation performance 
for strain BuT‑9
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interconvert NADPH and NADH [23]. Therefore, strain 
BuT-10 was obtained by further fusion udhA of strain 
BuT-9 with PλPL to enhance its expression. As compared 
to strain BuT-9, strain BuT-10 displayed twofold higher 
Zwf activity and a 10 % increase in the n-butanol produc-
tion (4.9 g/L) (Table 1; Fig. 3a).
The developed strain is derived from strain BL21 which 
lacks pgl [24], a gene encoding lactonase that is respon-
sible for the reaction following Zwf in the PP pathway. 
It is likely that yieK with an annotated function of Pgl is 
functioning in E. coli B strain but less active. Therefore, 
the carbon flux channeled into the PP pathway by ele-
vated Zwf may be limited at the Pgl-mediated reaction 
step. To address this issue, the PλPL-driven pgl from E. 
coli K-12 strain was re-introduced into strain BuT-10. 
Finally, the resulting strain (BuT-12) enabled production 
of 5.4 g/L n-butanol (Fig. 3b). As compared to strain BuT-
10, strain BuT-12 displayed a tenfold higher Pgl activity, 
a 36  % more NADH, and a 25.6  % improvement in the 
n-butanol production (Table 1). The approach by enhanc-
ing the PP pathway results in more NADH production, 
which drives more acetyl-CoA into the synthetic pathway 
of n-butanol. This is supported by the observed decrease 
in pyruvate and succinate (Table 2).
It is apparent that redistribution of carbon flux in gly-
colysis and the PP pathway can greatly affect intracel-
lular NADH level. Notice that entry of one glucose into 
the oxidative PP pathway generates two reducing equiv-
alents but wastes one CO2. Nevertheless, strain BuT-12 
which is manipulated at the pyruvate and G6P nodes 
displays a 96 % increase in the NADH level and doubles 
the n-butanol production as compared to strain BuT-8 
(Table 1).
Rerouting catabolic pathways of glucose
According to the central metabolism of E. coli (Fig.  1), 
glucose catabolism proceeding via the PP pathway gen-
erates 85 % more reducing power per gram mole of glu-
cose than that via glycolysis. It seems useful to increase 
intracellular NADH by diverting the glycolytic flux to the 
PP pathway. Phosphoglucose isomerase (encoded by pgi) 
is responsible for isomerization of G6P, and its inactiva-
tion makes the PP pathway the primary route of glucose 
catabolism [25]. Therefore, strain BuT-13 was obtained 
by deletion of pgi in strain BuT-12. In comparison with 
strain BuT-12, strain BuT-13 grew poorly (0.31/h vs. 
0.5/h), while it exhibited a 32 % and 30 % decrease in bio-
mass yield and glucose utilization, respectively (Fig.  4). 
After fermentation for 30  h, strain BuT-13 was unable 
to consume all glucose and produced less n-butanol 
(4.6 g/L).
Improving NADPH availability was realized by a 
strain deprived of pgi, whereas the strain showed a 47 % 
decrease in the specific growth rate [26]. The severe 
growth defect resulting from pgi knockout is attributed 
to a surplus of NADPH, which in turn perturbs the physi-
ological state of cells [27]. Interestingly, an elevated level 
of either UdhA or Zwf can lead to growth recovery of 
Table 1 Summary of the fermentation kinetics for main engineered strains
a The kinetic data were drawn from the previous report [19]. The development course of producer strains for the n‑butanol production was shown in Additional file 1: 
Fig. S1. U μmole/min, YB the n‑butanol titer, ND not determined
Strain YB (g/L) PB (g/L/h) YB/G (g/g) NADH (μmol/g cell) Specific enzyme activity  
(U/mg protein)
PDH Zwf Pgl GltA
BuT‑8 2.7a 0.11a 0.14a 42.2 0.7 ND ND ND
BuT‑9 4.3 0.18 0.22 60.9 1.6 6.1 ND ND
BuT‑10 4.9 0.20 0.25 75.8 18.3 0.5 ND ND
BuT‑12 5.4 0.23 0.27 82.6 ND ND 6.2 2.2
BuT‑14 6.1 0.21 0.31 96.1 ND ND ND 1.5
Table 2 Carbon recovery of fermentation products for engineered strains during the oxygen-limited growth on glucose
Carbon recovery was calculated as the molar percent of carbon in products per carbon in consumed glucose. Nil, carbon recovery less than 0.01
Strain Pyruvate Succinate Ethanol Lactate Acetate Butyrate Butanol Total (%)
BuT‑8 20.7 3.5 7.8 2.7 1.5 4.1 21.9 62.2
BuT‑9 2.6 2.1 5.2 1.8 1.2 2.7 34.8 50.4
BuT‑10 0.01 1.1 5.2 1.5 0.8 2.0 39.6 50.2
BuT‑12 Nil 0.8 5.2 1.4 0.7 1.4 43.7 53.2
BuT‑14 Nil 0.6 2.6 1.3 0.5 1.4 49.4 55.8
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the pgi-deficient strain by 25 and 68 %, respectively [27, 
28]. Strain BuT-13 is still afflicted by the growth defect 
although it exhibits higher UdhA and Zwf activities and 
harbors the n-butanol synthetic pathway that consumes 
the reducing equivalent. The result implies the presence 
of an imbalanced redox state in the strain.
In response to the oxygen tension, the TCA cycle 
operates as either an oxidative pathway or a reductive 
pathway associated with production of various levels 
of reducing equivalents [4]. Citrate synthase (encoded 
by gltA) catalyzes the first committed step in the TCA 
cycle (Fig.  1). The approach to divert carbon flux from 
the TCA cycle by lowering the GltA activity is expected 
to conserve acetyl-CoA (the precursor of n-butanol ) and 
modulate production of reducing equivalents. It may be 
helpful to ameliorate the negative impact on the strain 
imposed by null pgi. This was carried out by replace-
ment of the gltA cognate promoter P2 with lacO site in 
strain BuT-13. The resulting strain BuT-14 was then cul-
tured and examined for its fermentation performance. 
Consequently, strain BuT-14 grew almost normally (ca. 
0.46/h), and its biomass yield was comparable to strain 
BuT-12. All fermentation byproducts were significantly 
reduced in strain BuT-14 which consequently produced 
6.1 g/L n-butanol at 29 h (Table 2; Fig. 5). As expected, 
strain BuT-14 exhibited 32 % less GltA activity and 16 % 
more NADH as compared to strain BuT-12. Direction 



























































































Fig. 3 Production of n-butanol in strains with the amplification of 
the PP pathway. The engineered E. coli strains were grown in M9Y 
medium containing 20 g/L glucose. The fermentations were con‑
ducted under the oxygen‑limited condition for 24 h. The experiments 
were conducted in triplicate. Keys: a the fermentation performance 
for strain BuT‑10; b the fermentation performance for strain BuT‑12












































Fig. 4 Production of n-butanol in the strain with the glucose 
catabolism via the PP pathway. Strain BuT‑13 grown in M9Y medium 
containing 20 g/L glucose. The fermentations were conducted 
under the oxygen‑limited condition for 30 h. The experiments were 
conducted in triplicate



































Fig. 5 Time course of n-butanol production in the strain with the 
limited TCA cycle. Strain BuT‑14 grown in M9Y medium containing 
20 g/L glucose. The fermentations were conducted under the oxy‑
gen‑limited condition. The experiments were conducted in triplicate
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increases the reducing equivalent, whereas prevention 
of carbon flux from entering the TCA cycle by lowering 
GltA reduces the reducing equivalent. It leads to a net 
outcome of a moderate increase in NADH, which suf-
fices the need for the synthesis of n-butanol. As a result, a 
redox-balanced state is established in strain BuT-14 that 
recovers from the null pgi-induced growth defect. It was 
intriguing to learn the response of this strain to the act of 
further lowering the GltA activity. Strain BuT-14-A was 
thus obtained by integration of lacIQ into strain BuT-14. 
Consequently, strain BuT-14-A displayed 50 % less GltA 
activity than strain BuT-12 (Table 1). The strain exhibited 
a poor growth and consumed only 40  % glucose asso-
ciated with the n-butanol production of 1.8  g/L at 30  h 
(data not shown). It was reported that the growth of E. 
coli on glucose remains unaffected by a 90  % decrease 
in the GltA activity [29]. In contrast, the growth of the 
n-butanol-producing strain that lacks pgi on glucose is 
closely linked to the GltA activity. By modulation of the 
GltA activity, the producer strain enables recovery from 
the growth defect caused by null pgi. It is likely that the 
alteration of the GltA activity perturbs the intracellu-
lar redox state of the strain. Apparently, the engineered 
strain displays high susceptibility to the intracellular 
redox state and optimal adjustment of GltA activity is 
necessary to ensure the superior performance of the 
strain.
Recruitment of FDH and enhanced expression of PDH 
have been proposed to increase NADH availability favor-
ing the n-butanol production in E. coli. In one study, the 
approach by recruiting FDH achieved the n-butanol pro-
ductivity (PB) of 0.2  g/L/h and the conversion yield on 
glucose (YB/G) of 0.36  g/g [17]. An alternative study by 
manipulating PDH reported PB of 0.065  g/L/h and YB/G 
of 0.19  g/g [15]. In addition, PB of 0.26  g/L/h and YB/G 
of 0.27 g/g were obtained by optimization of both FDH 
and PDH activity in a recent work [18]. All these stud-
ies were conducted with super-rich TB medium, and 
plasmids were employed for the episomal expression of 
multiple target genes to increase their expression levels, 
which is important to obtain the observed effect. There-
fore, the discrepancy in the fermentation production by 
these reports is likely attributed to various expression 
levels of the cloned genes. However, plasmid mainte-
nance is known to impose a metabolic burden on cells, 
thus resulting in a reduced growth rate and perturbation 
of the cell physiology [30]. A metabolic load is addition-
ally imposed on E. coli after the forced expression of the 
plasmid-borne genes, which suppresses the primary car-
bon and energy metabolism of cells [31]. The use of TB 
medium (12 g/L tryptone, 24 g/L yeast extract, 2.31 g/L 
KH2PO4, 12.54 g/L KHPO4, 4 mL/L glycerol) is expected 
to improve the cell growth under the anaerobic condi-
tion and helps to ameliorate the plasmid-induced stress 
on cells. It should be noted that components other than 
glucose in the TB medium could contribute 15 % of the 
n-butanol production according to the previous study 
[17]. Therefore, these reported yields based on glucose 
may be re-estimated. In contrast, the engineered strains 
were free of plasmids and grown on the M9Y medium 
with glucose in this study. First, the starter strain BuT-8 
displayed PB of 0.11 g/L/h and YB/G of 0.14 g/g (Table 1). 
With both enhanced FDH and PDH, strain BuT-9 
achieved PB of 0.18  g/L/h and YB/G of 0.22  g/g. Finally, 
strain BuT-14 was developed by rerouting of the gly-
colytic flux through the PP pathway and further reduc-
ing GltA activity in the TCA cycle. It exhibited 2.3-fold 
higher NADH and n-butanol production titer than the 
starter strain BuT-8. Notice that n-butanol was not pro-
duced for strain BuT-14 grown on M9Y medium with-
out glucose (data not shown). Therefore, the n-butanol 
production in the strain comes merely from glucose. 
As a result, strain BuT-14 displayed PB of 0.21 g/L/h and 
YB/G of 0.31  g/g. In theory, 0.85  mol instead of 1  mol 
n-butanol per mole glucose is produced in the glucose 
catabolism via the PP pathway due to CO2 loss, which 
leads to the theoretical yield of n-butanol as 0.35  g/g. 
Accordingly, n-butanol remains the main product for 
strain BuT-14 (Table  2) with YB/G reaching 89  % of the 
theoretical. It is feasible to recycle CO2 in E. coli with the 
expression of Synechococcus ribulose-1,5-bisphosphate 
carboxylase/oxygenase (Rubisco) and phosphoribuloki-
nase [32]. The issue of increasing YB/G may be addressed 
by recruitment of the Rubisco-based CO2 recycling sys-
tem in strain BuT-14. Overall, it indicates that our pro-
posed approach is effective for production of the highly 
reduced product without the need for a super-rich 
medium.
Conclusions
The intracellular redox state in microbes is recognized 
as a key factor determining the production efficiency of 
fermentation products. The current work illustrates that 
pyruvate, G6P, and acetyl-CoA at the junction of the cen-
tral catabolism are flexible for engineering. It is known 
that the enzymes, such as PDH and GltA, involved in the 
use of these metabolite nodes are subjected to the physi-
ological control mediated by the effector metabolites [4]. 
Nevertheless, genetic manipulation of these metabo-
lite nodes can lead to the redistribution of carbon flux, 
which in turn alters the cellular redox state. In principle, 
these metabolite nodes can be individually or coordi-
nately modulated to fulfill the intracellular need for high 
production of reduced products of interest.
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Methods
Bacterial culturing
The method for bacterial culturing under the oxygen-
limited condition essentially followed the previous report 
[19]. The seeding cultures were prepared by growing E. 
coli strains on Luria–Bertani medium [33] with 2  g/L 
glucose overnight. The cell density was measured turbi-
dimetrically at 550  nm (OD550). The overnight culture 
was inoculated into capped Erlenmeyer flasks (125  mL) 
containing 50 mL M9Y medium (6 g/L Na2HPO4, 3 g/L 
KH2PO4, 0.5  g/L NaCl, 1  g/L NH4Cl, 1  mM MgSO4, 
0.1 mM CaCl2, 10 mg/L vitamin B1, 5 g/L yeast extract) 
with 20  g/L glucose to attain the initial cell density at 
OD550 of 0.2. The shake`flask cultures were maintained in 
an orbital shaker set at 100 rpm.
Strain construction
The strains and primers applied in this study are listed in 
Table 3. Genomic insertion of fdh1 into strain BuT-8 was 
constructed previously [34]. In brief, Ptrc-driven fdh1 of 
S. cerevisiae was amplified from plasmid pTrc-Fdh1 [21] 
by PCR with primers RC12171/RC12314. After digestion 
with BamHI, the PCR DNA was spliced into BamHI-
NruI of plasmid pP21-Km to obtain plasmid pP21-Fdh1. 
Based on our reported methods, the DNA containing 
Ptrc-fdh1 was then integrated into E. coli using plasmid 
pP21-Fdh1, and the inserted kanamycin-resistant marker 
in the strain was later removed [35]. Strain BuT-8 with 
fdh1 was renamed BuT-8-Fdh1.
Plasmid pMCS-lpdA was obtained by PCR-amplifica-
tion of lpdA from strain BL21 with primers RC12154/
RC12155 and subsequent incorporation into NdeI-XhoI 
of plasmid pMCS-5. The E354K mutation was introduced 
into lpdA on plasmid pMSC-lpdA by the site-directed 
mutagenesis using primers RC12215/RC12216. The 
mutant lpdA (lpdA*) was confirmed by DNA sequenc-
ing and removed from plasmid pMCS-lpdA by NdeI-
XhoI. The recovered lpdA* was subcloned into plasmid 
pLoxKm-PR [36] which carries a cassette of PλPL fused 
with LE*-kan-RE* (LE*-kan-RE*-PλPL). The resulting 
plasmid pLoxKm-lpdA* contains the LE*-kan-RE*-PλPL-
regulated lpdA* (LE*-kan-RE*-PλPL-lpdA*). Meanwhile, 
the upstream region of lpdA was amplified by PCR with 
primers RC12289/RC12290 and spliced into BamHI-SacI 
of plasmid pBluescript to produce plasmid pBlue-ac. The 
DNA containing LE*-kan-RE*-PλPL-lpdA* was recov-
ered from plasmid pLoxKm-lpdA* by BamHI-XhoI and 
then incorporated into plasmid pBlue-ac to give plas-
mid pBlue-ac/lpdA*. In addition, PCR was conducted 
on plasmid pBlue-ac/lpdA* with primers RC11210/
RC12331. The PCR DNA was digested with EcoRI and 
self-ligated to give plasmid pBlue-Ac-lpd, which carries 
lpdA interrupted with LE*-kan-RE*. To knockout lpdA, 
Table 3 The strains and primers applied in this study
Characteristics Source
Strains
BuT‑8 ΔfrdA ɸ80attB:: PλPL‑crt
ΔadhE::ɸ80attB::PλPL‑pha‑hbd
ΔldhA::λattB::PλPL‑adhE2 19
BuT‑8‑Fdh1 as P21attB:: Ptac‑fdh1 34




BuT‑10 as But‑9 PλPL‑zwf PλPL‑UdhA This study
BuT‑12 as But‑10 ΔatoD::PλPL‑pgl This study
BuT‑13 as But‑12 ∆pgi This study
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the truncated lpdA was amplified from plasmid pBlue-
Ac-lpd by PCR with primers RC12288/RC12290 and 
electroporated into E. coli following our protocol. Finally, 
the DNA containing PλPL-lpdA* was amplified from 
plasmid pBlue-ac/lpdA* by PCR with primers RC10178/
RC12288 and then restricted by BamHI. Plasmid pLam-
LpdA* was obtained by incorporation of the PCR DNA 
into BamHI-EcoRV of plasmid pLam-Crt [36]. Similarly, 
the DNA containing PλPL-lpdA* was integrated into E. 
coli followed by removal of the inserted marker [21].
To enhance the expression of endogenous genes, PλPL 
was placed in front of the structural genes with their cog-
nate promoters intact. This was carried out as follows: 
First, the upstream region and 5′-end structural regions 
of zwf, udh, and aceE were amplified from strain BL21 
by PCR with primers RC11403/RC11404, RC11407/
RC11408, and RC12085/RC12086, respectively. Each 
PCR DNA was digested by KpnI-SacI and incorporated 
into plasmid pBluescript to obtain plasmid pBlue-zwf, 
pBlue-udhA, and pBlue-aceE. Secondly, the NdeI-BamHI 
site was introduced into plasmid pBlue-zwf and pBlue-
udhA by PCR with primers RC11405/RC11406 and 
RC11409/RC11410 while the NdeI-XbaI site into plas-
mid pBlue-aceE with primers RC12058/RC12059. The 
LE*-kan-RE*-PλPL cassette was recovered from plasmid 
pLoxKm-PR by NdeI-BamHI or NdeI-XbaI digestion and 
then incorporated into plasmid pBlue-zwf, pBlue-udhA, 
and pBlue-aceE to obtain plasmid pPR-zwf, pPR-udhA, 
and pPR-aceE. Finally, the PCR DNAs were amplified 
from plasmid pPR-zwf, pPR-udhA, and pPR-aceE with 
primers RC11417/RC11418, RC11419/RC11420, and 
RC12060/RC12086, respectively. These passenger DNAs 
were individually integrated into the strain by electropo-
ration according to the reported method [21]. The associ-
ated marker was finally rescued.
To obtain pgl, the gene was amplified from strain 
MG1655 with primers RC13292/RC13293. After cleav-
age by EcoRV-SacI, the PCR DNA and plasmid pBlue-
script were spliced together to give plasmid pBlue-pgl. 
The pgl-containing DNA was recovered by SmaI-XhoI 
and incorporated into plasmid pLoxKm-PL. The con-
struction resulted in plasmid pSPL-pgl, which fuses 
LE*-kan-RE*-PλPL with pgl. The LE*-kan-RE*-PλPL-
pgl DNA was amplified by PCR with primers RC13001/
RC13293. Plasmid pAto-pgl was obtained by incor-
poration of the PCR DNA into EcoRI-NruI of plasmid 
pSPL-atoD [36]. Similarly, the passenger DNA was ampli-
fied from plasmid pSPL-atoD with primers RC13034/
RC13035 and then electroporated to the strain. Later 
removal of the inserted marker was carried out.
To modulate the gltA expression, its P2 promoter was 
replaced with lacO. This was done in several steps. First, 
lacO was created in plasmid pLoxKm-PR by PCR with 
primers RC13195/RC13196. After cleavage by SmaI, the 
PCR DNA was self-ligated to produce plasmid pLoxCm-
LacO, which carries the fusion of LE*-kan-RE*-lacO. 
Secondly, the DNA containing the upstream region and 
5′-end structural sequence of gltA was amplified from 
strain BL21 by PCR with primers RC13197/RC13198. 
Plasmid pBlue-GltA was generated by incorporation of 
the PCR DNA into KpnI-SmaI of plasmid pBluescript. 
Moreover, the ApaI-SalI site was introduced into plasmid 
pBlue-GltA by PCR with primers RC13199/RC13200. 
The LE*-kan-RE*-lacO cassette was recovered from plas-
mid pLoxCm-LacO by ApaI-SalI and incorporated into 
plasmid pBlue-GltA to give plasmid pBlue-GltO. Finally, 
the FRT-Cm-FRT cassette was amplified from plasmid 
pKD3 by PCR with primers RC14025/RC14026. The LE*-
kan-RE* cassette was replaced by FRT-Cm-FRT by incor-
poration of the PCR DNA into EcoRI-SalI of plasmid 
pBlue-gltO, leading to plasmid pB-gltO-Cm. The passen-
ger DNA was amplified from plasmid pB-gltO-Cm with 
primers RC13197/RC13201 and then electroporated to 
the strain in a similar way.
Analytical method
The analytical method essentially followed our reported 
protocol [19]. Glucose was measured by high-perfor-
mance liquid chromatography (HPLC) with Reflective 
Index RID-10A (Shimadzu, Japan). n-Butanol was deter-
mined by Gas Chromatograph Trace 1300 (Thermo Sci-
entific, USA).
The intracellular NADH level was measured by using 
the fluorescent NAD/NADH detection kit (Cell Tech-
nology, USA). The assay procedure exactly followed the 
manufacturer’s instruction. In brief, bacterial cultures 
were harvested by centrifugation and the cell pellets 
were resuspended in 200  µL NADH extraction buffer 
plus 200  µL lysis buffer. The mixture was kept at 60  °C 
for 20  min. After centrifugation, the supernatant was 
recovered and mixed with the reaction reagent for the 
measurement. The reaction was kept in dark at room 
temperature for 1  h. The NADH level was then meas-
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Enzyme activity assay
Bacterial cultures were harvested by centrifugation and 
the cell pellets were resuspended in 1 mL solution buffer. 
Cells were disrupted by sonication after centrifugation. 
The supernatant was saved as the cell-free extract (CFX). 
The total protein content in CFX was determined using 
Bio-Rad protein assay kit. The activity of pyruvate dehy-
drogenase was determined by monitoring the reduction 
of NAD+ at 340  nm at room temperature according to 
the previous report [15]. The reaction solution (1  mL) 
contains 50  mM potassium phosphate (pH 7.9), 5  mM 
sodium pyruvate, 1.3  mM CoA, 2  mM NAD+, 0.5  mM 
thiamine pyrophosphate, and 5  mM MgCl2. To start 
the reaction, 100  µL CFX was added to the solution. 
The activity of glucose-6-phosphate dehydrogenase was 
determined by monitoring the reduction of NADP+ at 
340 nm following the reported protocol [37]. The reaction 
solution (1  mL) is composed of 2  mM glucose-6-phos-
phate, 0.67  mM NADP+, 10  mM MgCl2, and 50  mM 
Tris–HCl (pH 7.5). The reaction was initiated by add-
ing 100 µL CFX to the solution at 30 °C. The method for 
measuring the activity of lactonase was similar to the glu-
cose-6-phosphate dehydrogenase activity assay [38]. The 
reaction solution comprises 50 μM glucose-6-phosphate, 
0.5 mM NADP+, 50 mM Tris–HCl, 10 mM MgCl2, and 
50  mM Tris–HCl (pH 7.5). In addition, the citrate syn-
thase activity was measured as reported previously [29]. 
The composition of the assay solution includes 0.1  mM 
acetyl-CoA, 0.5 mM oxaloacetate, 0.2 mM 5′5-dithiobis-
(2-nitrobenzoic acid), and 50 mM Tris–HCl (pH 7.5).
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